NVP-ACC789
ACC-789 (NVP-ACC789, ZK-202650) is a potent, selective, and orally bioavailable inhibitor targeting VEGF receptor tyrosine kinases. It is utilized in cancer research, particularly in studies of angiogenesis, and has demonstrated activity in both in vitro cellular assays and in vivo tumor models.
Product Specifications
CAS Number
300842-64-2
Product Name Alternative
Platelet-derived growth factor receptor, NVP-ACC 789, NVPACC789, NVP-ACC789, NVP-ACC-789, NVP ACC789, ACC789, ACC-789, ACC 789, ZK202650, ZK-202650, ZK 202650, PDGFR, PDGFRβ, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.93 mM) ; DMSO:60 mg/mL (148.04 mM)
Smiles
Cc1ccc (Nc2nnc (Cc3ccncc3) c3ccccc23) cc1Br
Molecular Formula
C21H17BrN4
Molecular Weight
405.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6256356-01 0.1 mL
Talin (KIAA1027, TLN, TLN1, ILWEQ) (MaxLight 650)
Sign In for Pricing
View Details MBS6256356-02 5x 0.1 mL
Talin (KIAA1027, TLN, TLN1, ILWEQ) (MaxLight 650)
Sign In for Pricing
View Details AM4164 2 OD, 4 OD, 50 OD
MIRacle™ mmu-miR-3063-5p miRNA Agomir/Antagomir
Sign In for Pricing
View Details